Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Wednesday
May 22nd
Home arrow Farmavita.Net Journal arrow Approval of the Drug Product in India
Approval of the Drug Product in India Print E-mail
Life Sciences - Life Science Article

india-pic.jpg

India’s Marketing Regulations of Drugs

Approval of the drug product for import, manufacturing and marketing in India, its demonstration for safety and efficacy in humans is essential. The Rules 122A, 122B and 122D, 122 DA, 122DAA, 122E and Appendix I, IA and VI of Schedule Y of the Drugs & Cosmetics Act, 1945, describes the information/data required for approval of clinical trial and/or to import, manufacture, or market any new drug in the country. However, the requirements for approval of clinical trials and new drugs may vary depending on the nature of new drugs.

The whole 12 pages article is available for download at Downloads section of Farmavita.Net.

During the past decade, India has been actively reforming its key industrial sectors to compete at world-class levels. Its infrastructure development, technology base creation and a wide range of production has shown tremendous progress in the Indian pharmaceutical industry. These reforms have been motivated by its expanding global trade and a self-image that has moved beyond that of a developing country. India holding fourth ranks worldwide accounting to 8% of world’s production by volume and 1.5% by value. It ranks 17th in terms of export value of bulk actives and dosage forms. Indian exports are destined to more than 200 countries around the globe including highly regulated markets of US, Europe, Japan and Australia.

The vast pharma market of India is being rightly celebrated in international circles for making medicines in affordable prices. The undergoing rapid shifts in other industrializing countries, India clearly recognize the need to restructure its regulatory system in order to compete the biopharmaceutical industry among international markets. According to the authors, a new regulatory structure in India is being formed, to centralize drug approvals and tighten the still somewhat lax manufacturing practices that have led to a proliferation of poor ethical practices and substandard drugs.

The whole 12 pages article is available for download at Downloads section of Farmavita.Net.  

Comments
Add New Search RSS
Write comment
Name:
Email:
 
Website:
Title:
 
Please input the anti-spam code that you can read in the image.

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Related News
Newer news items
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network




Reddit!Del.icio.us!Google!Live!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Newsvine!Furl!Blogmarks!Yahoo!Ma.gnolia!FeedMeLinks!Free social bookmarking plugins and extensions for Joomla! websites!
 
< Prev   Next >
Advertisement
 

Featured Partners

 
logo_kvadrat_150x150.jpg    
lcm-150x150.jpg  
150-150-static.gif
apacma13_150x150_banner.gif  
  doctors20150x1501.png
bals137_150x150.gif
bals138_150x150.jpg
ch-150x150-an.gif 
pharmaccess13a_150x150.gif 

Login to Farmavita.Net

membership is FREE

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 5 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

150-150-static.gif

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif